Literature DB >> 16710996

Construction of rat calcineurin A alpha cDNA recombinant adenovirus vector and its identification.

Xiaomei Shen1, Juyan Zhang, Bei Cheng.   

Abstract

Rat calcineurin (CaN) A alpha isoform (Ppp3ca) cDNA recombinant adenovirus vector was constructed in order to explore the effect of CaN on the myocardium apoptosis induced by ischemia-reperfusion injury. Total RNA was isolated from the heart of the adult Wistar rat, and Ppp3ca CDS segment of approximate 1.59 kb size was amplified by reverse transcriptional PCR method. Ppp3ca cDNA segment was cloned into pMD18-T Simple vector for sequencing, and the right clone was named T-Ppp3ca. Ppp3ca cDNA segment obtained from T-Ppp3ca was ligated with pShuttle2-IRES-EGFP to construct a recombinant plasmid pShuttle2-Ppp3ca-IRES-EGFP. Ppp3ca-IRES-EGFP expression cassette containing CMV, Ppp3ca-IRES-EGFP and SV40 polyA DNA fragment (3.97 kb) obtained from pShuttle2-Ppp3ca-IRES-EGFP was connected with pAdeno-X backbone sequence to construct a recombinant plasmid pAdeno-Ppp3ca. After being identified by PCR and enzyme digestion, recombinant plasmid pAdeno-Ppp3ca was packaged in HEK293 cells. Supernatant of adenovirus from HEK293 cells was collected after a visible cytopathic effect (CPE) appeared. The DNA of the recombinant adenovirus was extracted with the standard method. The presence of the recombinant adenovirus was verified by PCR. The results showed that sequencing results verified that the PCR product of Ppp3ca gene was identical to GenBank. Agarose electrophoresis showed the bands of recombined plasmid pAdeno-Ppp3ca and the recombinant adenovirus identified by enzyme digestion and PCR were in the right range corresponding with expectation. It was concluded that the recombinant adenovirus carrying rat calcineurin A alpha (Ppp3ca) cDNA as well as a report gene-enhancer green fluorescent protein gene was successfully constructed in this experiment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710996     DOI: 10.1007/bf02828025

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  Calcineurin: not just a simple protein phosphatase.

Authors:  D Guerini
Journal:  Biochem Biophys Res Commun       Date:  1997-06-18       Impact factor: 3.575

2.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

3.  Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes.

Authors:  T Kakita; K Hasegawa; E Iwai-Kanai; S Adachi; T Morimoto; H Wada; T Kawamura; T Yanazume; S Sasayama
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

4.  Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.

Authors:  A Murat; C Pellieux; H R Brunner; T Pedrazzini
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin.

Authors:  Z Wang; W Kutschke; K E Richardson; M Karimi; J A Hill
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

6.  GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism.

Authors:  J R González-Juanatey; R Piñeiro; M J Iglesias; O Gualillo; P A Kelly; C Diéguez; F Lago
Journal:  J Endocrinol       Date:  2004-02       Impact factor: 4.286

7.  Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes.

Authors:  A Soloviev; A Stefanov; A Parshikov; A Khromov; A Moibenko; L Kvotchina; G Balavoine; Yu Geletii
Journal:  Cardiovasc Toxicol       Date:  2002       Impact factor: 3.231

8.  Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria.

Authors:  Magnus J Hansson; Tanja Persson; Hans Friberg; Marcus F Keep; Anthony Rees; Tadeusz Wieloch; Eskil Elmér
Journal:  Brain Res       Date:  2003-01-17       Impact factor: 3.252

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.